Virtual Reality in Reducing Acute Orthopedic Pain

N/ANot Yet RecruitingNCT06624969

Mayo Clinic100 enrolled

Overview

The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Fractures

Interventions

virtual realityOTHER

Virtual reality program to reduce pain in orthopedic fractures

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Hospitalized with an orthopedic fracture 2. Able to participate fully in all aspects of the study 3. Able to understand and sign informed consent 4. Individuals with unaided vision or those who can correct their vision using contact lenses Exclusion Criteria: 5. Non-English speaking 6. Self-reported history of acute and/or chronic severe motion sickness 7. The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display. 8. Legally blind or deaf 9. Have had a seizure within the past 1 year 10. Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder 11. Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

Outcomes

Primary Outcomes

opioid use

Change in opioid equivalents during hospital stay from hospital admission to discharge

Time frame: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

Secondary Outcomes

reduction in anxiolytics

Change in anxiolytics during the hospital admission from admission to discharge

Time frame: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

hospital length of stay

Time frame: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

reduction in sleep aids prescribed

Change in sleep aids prescribed during the hospital stay from hospital admission to discharge

Time frame: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

User experiences

Subjective user experiences with the virtual reality program obtained at hospital discharge using a questionnaire with Likert scale answers showing higher scores to have better experiences with the intervention

Time frame: obtained once on the day of hospital discharge, up to 5 weeks from study enrollment

Central Contacts

Scott Helgeson, MD

CONTACT

904-953-2000 helgeson.scott@mayo.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.